Patent · US Active

Compositions and their uses directed to huntingtin

US7951934B2 · kind B2 · utility

45Cited by
9References
23Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 26, 2007
Grant dateMay 31, 2011
Priority date
Expiry dateJan 26, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's disease progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntingtin's disease in an individual susceptible to Huntingtin's Disease. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.